ProCE Banner Activity

BRCA Testing and Adjuvant Therapy in Early Breast Cancer: Experiences and Challenges

Podcast Episodes

Multidisciplinary specialists discuss the role of BRCA testing and adjuvant olaparib in early breast cancer, including their experiences and challenges with implementing recent data.

Released: April 04, 2023

Share

Faculty

Banu Arun

Banu Arun, MD

Professor, Breast Medical Oncology
Co-Director, Clinical Cancer Genetics 
Executive Director, Cancer Genetics
MD Anderson Cancer Networks
University of Texas MD Anderson Cancer Center
Houston, Texas

Allison Butts

Allison Butts, PharmD, BCOP

Clinical Pharmacy Specialist, Breast Oncology
Pharmacist Manager, Oncology
Program Director, PGY2 Hematology/Oncology Pharmacy Residency
UK Healthcare
Lexington, Kentucky

Marissa Marti-Smith

Marissa Marti-Smith, APRN, AGNP-C, AOCNP

Nurse Practitioner
Breast Oncology
Texas Oncology Baylor Sammons Cancer Center
Dallas, Texas

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

Merck Sharp & Dohme, LLC

Partners

ProCE

ProCE Banner

 In partnership with ProCE, LLC

Faculty Disclosure

Banu Arun, MD: researcher: AstraZeneca.

Allison Butts, PharmD, BCOP: consultant/advisor/speaker: AstraZeneca, BeyondSpring.

Marissa Marti-Smith, MSN, APRN, AGNP-C, AOCNP, has no relevant financial relationships to disclose.